Acetyl hexapeptide-3

DB11709InvestigationalSmall molecule

Argireline has been used in trials studying the treatment of wrinkles.

Mechanism: Pharmacologically active on Synaptosomal-associated protein 25
Curator reviewed
Formula / weight: C₃₅H₆₂N₁₄O₁₁S · 887.03 g/mol (avg)
Also known as: Acetyl hexapeptide-8 · Argireline · Argireline NP · Hexapeptide 3

Resolves to

Compound

Clinical / RWD

Structure

CSCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=C)[C@H](CCC(O)=O)NC(C)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

6Marketed productsAcross 1 country and 5 labellers

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Acetyl hexapeptide-3, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.